Medical Research Future Fund (MRFF): Current Funding Opportunities
Do you want to know more about the MRFF? See AAMRI’s summary here.
Impact of COVID-19 on MRFF grants
On April 1 2020, the Health and Medical Research Office (Department of Health) published a statement on the MRFF website announcing that some Medical Research Future Fund grants will be delayed due to the impact of the COVID-19 pandemic on the sector. The only delayed grant round that was announced was the Frontier Health and Medical Research Initiative. On 7th October 2020, the grant round re-opened with revised guidelines combining both Stage One and Stage Two in one process (See Table 1 below and GrantConnect GO4359).
For further information, see the MRFF website and subscribe to the MRFF monthly newsletter.
MRFF monthly newsletter – subscribe now
The Health and Medical Research Office releases a monthly newsletter about the MRFF, providing the latest news and information including open grant opportunities.
Past MRFF newsletters are available in the archive on the Department of Health website here.
MRFF grant outcomes and funding recipients
Where available, AAMRI will include the outcomes of MRFF funding rounds in Table 2 below. A list of all contracted recipients of MRFF funding is available here (current at 2 December, 2020). A summary of grants and funding awarded through competitive and targeted schemes is provided here, for all MRFF grants as well as for grants awarded in 2019-2020.
Current and upcoming MRFF Funding Opportunities
See our summary below for current MRFF grant opportunities, open and closing dates for applications and how to apply. A list of closed application rounds and grant outcomes (where available) is also provided below.
- Table 1: Current and upcoming MRFF Funding Opportunities
- Table 2: Closed MRFF funding rounds and grant outcomes
In accordance with s24 of the Medical Research Future Fund Act 2015 , you must be one of the following bodies to be eligible for MRFF funding:
- a medical research institute
- a university
- a corporate Commonwealth entity
- a corporation (including businesses and not for profits).
- a state or territory government
- a state or territory government entity
Joint applications are encouraged, provided you have a lead organisation that is the main driver of the project and is eligible to apply.
Table 1
| Grant and Initiative | Applicant type, project type and objectives of initiative | Managing Agency | Key application dates | How to apply |
|---|---|---|---|---|
| 2021 Innovative Therapies for Mental Illness - Grant Opportunity GO4726 $15M Part of the Clinical Trials Activity Initiative | APPLICANT TYPE: Applications must be from NHMRC administering institutions OBJECTIVES: The Clinical Trials Activity Initiative (the Initiative) aims to enable or support: − New opportunities for clinical trial participation and associated benefits from accessing the latest research by members of the Australian community living with a medical condition for which there are limited effective treatment options. − Attention given to under-researched health priorities and conditions, such as rare cancers and rare diseases. − Deployment of innovative trial designs and recruitment strategies to provide high-quality evidence of the efficacy of new health treatments, drugs and devices. − Purposeful health service engagement to improve the translation of research into practice and improve outcomes for patients. − Implementation of new health treatments, drugs and devices to improve health and wellbeing. − Reinforcement of Australia’s position as a preferred destination for clinical trials. | NHMRC | Closes 21 July 2021 Minimum data due 7 July 2021 | Apply through NHMRC's Sapphire Grant guidelines are available on Grant Connect |
| MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity GO4824 $70M Part of the Clinical Trials Activity Initiative | APPLICANT TYPES: Applications must be from NHMRC administering institutions. OBJECTIVE: The Clinical Trials Activity (Rare Cancers, Rare Diseases and Unmet Need (RCRDUN)) Initiative (the Initiative) aims to enable or support: − New opportunities for clinical trial participation and associated benefits from accessing the latest research by members of the Australian community living with a medical condition for which there are limited effective treatment options. − Attention given to under-researched health priorities and conditions, such as rare cancers and rare diseases. − Deployment of innovative trial designs and recruitment strategies to provide high-quality evidence of the efficacy of new health treatments, drugs and devices. − Purposeful health service engagement to improve the translation of research into practice and improve outcomes for patients. − Implementation of new health treatments, drugs and devices to improve health and wellbeing. − Reinforcement of Australia’s position as a preferred destination for clinical trials. | NHMRC | Stream 2 Minimum data: 23 June 2021 Closes 7 July 2021 Streams 1, 3, 4, 5, 6, 7 Minimum data: 4 August 2021 Closes 18 August 2021 | Apply through NHMRC's Sapphire Grant Guidelines are available on Grant Connect |
| MRFF – 2021 COVID 19 Health Impacts and Vaccination Schedules Grant Opportunity $15M Part of the Emerging Priorities and Consumer-Driven Research initiative | APPLICANT TYPES: Applications must be from NHMRC administering institutions. OBJECTIVE: The objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that: - Stream 1: study individuals that have tested positive for COVID-191 to improve understanding of the long-term health impacts of COVID-19 - Stream 2: conduct clinical trials to generate evidence on how individuals or populations with immunocompromising conditions respond to COVID-19 vaccination, to inform vaccine schedules - Stream 3: conduct clinical trials to generate knowledge on the efficacy of vaccine schedules that combine different COVID-19 vaccines. | NHMRC | Minimum data: 4 August 2021 Closes: 18 August 2021 | Apply through NHMRC's Sapphire Grant Guidelines are available on Grant Connect |
Closed MRFF funding rounds and grant outcomes
Where available, AAMRI will include the outcomes of MRFF funding rounds in Table 2 below. A list of all contracted recipients of MRFF funding is available here (current at 30 October, 2020).
Table 2
| MRFF Initiative | Applicant type and purpose of initiative | Managing Agency | Closing date | Grant Outcomes and application process |
|---|---|---|---|---|
| 2020 Rapid Applied Research Translation Grant Opportunity GrantConnect ID GO4576 Up to $10M | APPLICANT TYPE: Two streams of funding are available based on the geographic location of the lead organisation: Stream 1: Organisations based in urban areas (any area according to the Modified Monash Model Locator ) Stream 2: Organisations based in rural areas (MM2 or above according to the Modified Monash Model). OBJECTIVES: To support Australian medical research and medical innovation projects that: - use existing knowledge to develop, test and implement new approaches for the translation of research findings into health care and health interventions that have potential for broader applicability; - address a clearly defined gap in the implementation of best practice health care and health interventions to improve health outcomes; and - involve all stakeholders relevant to the research and its translation in its conceptualisation, design and implementation, including health care consumers and providers. | Business.gov.au for the Department of Health | Open date: 04 Mar 2021 10:00 AM AEDT. Close date: 06 May 2021 05:00 PM AEST. | Apply through business.gov.au |
| 2020 Early Stage Translation and Commercialisation Support $79M GrantConnect FO Business Grants Hub | APPLICANT TYPE: Eligible organisations to work in partnership with Australian small to medium-sized enterprises to progress their medical research and medical innovation projects towards commercialisation. OBJECTIVE: to progress medical research and medical innovation projects through the early stages of development | Department of Health through the Business Grants Hub (business.gov.au) | Opens: 4 March 202110.00am AEDT. Closes: 1 April 2021 5.00pm AEST. | When this round opens, apply through business.gov.au |
| 2020 Clinician Researchers Applied Research in Health $25M GrantConnect GO4542 Business Grants Hub | APPLICANT TYPE: Eligible organisations seeking to improve better clinician research practices, capacity and outcomes for applied health. OBJECTIVE: To support medical research and innovation projects that validate and implement new approaches for improving the quality and consistency of patient care. Applicants must propose a research project that: - addresses a clearly defined health care priority from local health care and/or practice - has potential to improve clinical practice or health system effectiveness and therefore patient outcomes - is embedded within health services (e.g. community-based care, hospitals, general practices); however, it can also be coordinated across networks (e.g. Primary Health Networks, Local Health Networks). | Department of Health through the Business Grants Hub (business.gov.au) | Closes 12 April 2021 5.00pm AEST | Apply through Business Grants Hub Guidelines are available on GrantConnect and Business Grants HubA |
| 2020 Neurofibromatosis Research Grant Opportunity GrantConnect GO4641 $7M Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative | OBJECTIVES: To improve the health and wellbeing of Australians by generating knowledge that will lead to new interventions that reduce the clinical impact of neurofibromatosis. This funding aims to support Australian medical research projects that: - Stream 1: build knowledge of the factors that drive variation in the clinical presentation of neurofibromatosis for the purpose of generating new interventions - Stream 2: use clinical trials to test the effectiveness of new interventions for the treatment of neurofibromatosis. | NHMRC | Closes 7 April 2021 5.00pm AEST Minimum data due 24 March 2021 | Apply through NHMRC Grant guidelines and other essential documents are available on GrantConnect |
| Biomedtech horizons Round 4 4 X partnership opportunities worth $800,000 | APPLICANT TYPE: for organisations to help progress medical technologies and devices through to Proof of Concept or beyond, the point where they are attractive to secure further venture capital or other funding. OBJECTIVE: to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential. | MTPConnect | Closes 4 April 2021 | Apply through MTPConnect Grant guidelines |
| 2020 International Clinical Trial Collaborations Grant Opportunity GrantConnectID GO4317 Round 1 - $6.3M Round 2 - $6.3M Part of the MRFF Clinical Trial Activity Initiative | APPLICANT TYPES: Applications must be from NHMRC admininistering institutions. OBJECTIVE: To support clinical trials in Australia, in collaboration with international counterparts. Applications must address the desired outcomes described in section 1.3 of the grant guidelines. | NHMRC | ROUND 1 (2020-2021) Closes 11 November, 2020 5:00pm AEST Minimum data due 28 October, 2020 ROUND 2 (2020-2021) Closes 3 March, 2021 5:00pm AEST Minimum data due 17 February, 2021 | Apply through NHMRC's Sapphire Grant guidelines are available on GrantConnect |
| 2020 COVID-19 Vaccine Candidate Research grant opportunity Grants up to $3M Total funding available $13.65M GrantConnect ID: GO4088 Announced by Minister for Health, Greg Hunt, on 2nd June, 2020 | APPLICANT TYPE: Researchers and research teams. Applicants must also demonstrate access to critical resources necessary to complete the project in the stipulated timeframes. OBJECTIVES: To accelerate the development of promising COVID-19 prophylactic vaccine candidates for which research and development is already underway. Proposals must be focussed on research on a vaccine candidate that has progressed to pre-clinical or clinical investigation with proof-of-concept data. The intended outcome of the research is to support rapid development of a safe and effective COVID-19 prophylactic (disease-preventing) vaccine, which induces active long-term immunity, within the next 12-18 months. Applications must address the desired outcomes described in section 1.3 of the grant guidelines (available on GrantConnect - GO4088). | NHMRC (on behalf of the Department of Health) | Round 2 EOIs 11 November, 2020 Round 3 EOIs 10 March, 2020 - Up to three application rounds over 1 year (2020-21) - A round will comprise two application steps: expression of interest and full applications. | Apply via Sapphire, the NHMRC's new grant management system Grant guidelines available on GrantConnect (GO4088) -Applicants and RAOs should also note that the proportion of funds committed after Round 1 may determine whether further Rounds are opened. |
| 2020 Paediatric Cancer Grant Opportunity GrantConnect GO4559 $9.6M (grants up to $9.6M) Part of the Emerging Priorities and Consumer Driven Research Initiative | APPLICANT TYPE: A multi-centre program of research that brings together expertise from the Melbourne Biomedical Precinct (Parkville) and the Monash Technology Precinct. The program must complement existing research programs and incorporate research activities based at The Royal Children’s Hospital, Melbourne and Monash Children’s Hospital. OBJECTIVES: to support a co-ordinated program of Victorian medical research and medical innovation projects aimed at improving outcomes for children with cancer by improving: - basic knowledge about cancer in children - the clinical management of cancer in children, including the patient journey and survivorship | This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. | Closes 10 March, 2021, 5pm AEDT Minimum data - 24 February, 2021 5pm AEDT | Apply through NHMRC |
| 2020 Dementia, Ageing and Aged Care Grant Opportunity GrantConnect GO4569 $17.5M (grants up to $4M ea) Part of the Dementia, Ageing and Aged Care Mission | OBJECTIVES: The intended outcome of the research is to improve the health and wellbeing of Australians: Stream 1 (Targeted Call for Research (TCR)): living with dementia by supporting assessment and adoption of improved care delivery models Stream 2 (TCR): living with dementia and their carers by developing and supporting adoption of new patient centred care approaches Stream 3 (TCR): living with dementia by enabling earlier and more effective diagnosis and better understanding of disease progression Stream 4 (TCR): by reducing the incidence of infectious disease amongst residents in aged care settings and during transitions. | This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. | Closes 10 March, 2021, 5pm AEDT Minimum data - 24 February, 2021 5pm AEDT | Apply through NHMRC |
| 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity GrantConnect GO4535 $25M (grants up to $4M) Part of the EPCDR Initiati | OBJECTIVE: to support Australian medical research and medical innovation projects in one of the following streams: Stream 1: utilise existing evidence to develop or improve approaches for the early diagnosis of ovarian cancer, cancers of the pancreas, liver cancer or lung cancer that have a clinically feasible pathway to implementation Stream 2: enable approaches for the early diagnosis of cancers with unknown primary site that have a clinically feasible pathway to implementation. | This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. | Closes 10 March, 2021, 5pm AEDT Minimum data - 24 February, 2021 5pm AEDT | Apply through NHMRC |
| 2020 Genomics Health Futures Mission Grant Opportunity GrantConnect GO4560 $45M (grants $0.5M to $6M) Part of the Genomics Health Futures Mission | to support Australian medical research and medical innovation projects that: Stream 1 (Targeted Call for Research): identify and diagnose novel - primarily monogenic or oligogenic - rare diseases and increase the genomic diagnostic rate towards 70% by 2025. Stream 2 (Targeted Call for Research): improve early detection and targeted treatment for the most common cancers to reduce the burden of disease. Research proposals in this stream must focus on one of the following topics: - Topic A: discover clinically relevant biomarkers to improve early detection of common cancers - Topic B: develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention - Topic C: develop genomic screening tools for predictive disease modelling and to guide therapy. Stream 3 (Targeted Call for Research): promote diagnostic effectiveness and efficiency through better understanding of the impact of genetic variants through functional genomics by establishing a national functional genomics approach to enhance novel gene discoveries, increase diagnostic rates and enable disease modelling to support development of targeted therapies. All three Streams are intended to support large-scale interdisciplinary research. | This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. | Closes 3 March, 2021, 5pm AEDT Minimum data - 17 February, 2021 5pm AEDT | Apply through NHMRC |
| 2020 Stem Cell Therapies Grant Opportunity GrantConnect GO4571 $19M (grants up to $5M) | APPLICANT TYPE: Applications accepted from NHMRC Administering Institutions. Applications to Stream 5 (Targeted Call for Research) will only be accepted from the following institutions: - Australian Centre for Disease Preparedness via its Administering Institution Commonwealth Scientific and Industrial Research Organisation (CSIRO) - Curtin University - Griffith University - University of New South Wales - Translational Research Institute via its Administering Institution The University of Queensland - The Walter and Eliza Hall Institute of Medical Research. | This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. | Closes 3 March, 2021, 5pm AEDT Minimum data - 17 February, 2021 5pm AEDT | Apply through NHMRC |
| 2020 Cardiovascular Health Grant Opportunity GrantConnect GO4570 $20.28M (grants up to $3M) Part of the Cardiovascular Health Mission | OBJECTIVES: to support Australian medical research and medical innovation projects: - Stream 1 (Targeted Call for Research): providing new therapeutics and devices that prevent cardiovascular disease and/or stroke - Stream 2 (Targeted Call for Research): providing new interventions that promote rapid and more effective recovery following an acute cardiovascular disease and/or stroke event - Stream 3 (Incubator): generating new approaches that have the potential to transform care following a cardiovascular and/or stroke event. | This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. | Closes 3 March, 2021, 5pm AEDT Minimum data - 17 February, 2021 5pm AEDT | Apply through NHMRC |
| 2020 Traumatic Brain Injury Mission Grant Opportunity | OBJECTIVES: to improve the health and wellbeing of Australians by: - Stream 1 (Incubator): supporting the development of more effective, evidence-based care for moderate to severe TBI through increased knowledge - Stream 2 (Incubator): supporting health care providers to consistently deliver best practice treatment and care for moderate to severe TBI - Stream 3 (Targeted Call for Research): reducing the extent of harm caused by moderate to severe TBI by improving acute care practice - Stream 4 (Incubator): supporting health care providers to consistently deliver best practice treatments and care for mild TBI - Stream 5 (Targeted Call for Research): identifying strategies for improving community awareness of TBI and responses to people living with TBI. | Business.gov.au for the Department of Health | Closes 3 March, 2021, 5pm AEDT Minimum data - 17 February, 2021 5pm AEDT | Apply through NHMRC |
| Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease $47m | The TTRA program is designed to support and incentivise translation as a natural course of activity for those applying and receiving funding. The TTRA will: - Establish Research Centres for diabetes and cardiovascular disease - Establish a contestable Research Project funding program to support D&CVD research projects - Promote the clinical and commercial translation of innovative therapeutics, diagnostics, devices and digital solutions for D&CVD | MTPConnect | Closes 15 March 2021, 16:00 AEDT Call for Expressions of Interest is now open via MTPConnect. | Apply through MTPConnect |
| 2020 Indigenous Health Research Grant Opportunity GrantConnectID GO4582 $11.1M Grants up to $1.5m Part of the MRFF Indigenous Health Research Fund | OBJECTIVE: to improve the health and wellbeing of Aboriginal and/or Torres Strait Islander people by: - Stream 1 (Incubator): generating new approaches for community based practices that transform care in early life and for chronic diseases and generating knowledge that defines the positive role that culture can play in health and wellbeing and articulates how it can be incorporated into services and programs - Stream 2 (Targeted Call for Research): enabling Aboriginal and/or Torres Strait Islander led primary health care services and practitioners to undertake research of relevance to their communities and drive implementation of best practice outcomes. | NHMRC | Closes 10 March, 2021 12.00pm AEDT Minimum data due 24 February 2021, 5pm AEDT | Apply through NHMRC Grant guidelines, proposal templates, risk rating scale and scoring matrix for assessment are available on GrantConnect. |
| 2020 Childhood Cancer Research Grant Opportunity $9M GrantConnect ID GO4456 Part of the MRFF Emerging Priorities and Consumer Driven Research Initiative | The Grant Opportunity will fund projects in two streams of research: - $3M Cancers that occur in children aged 0-14 years. - $3M Cancers that occur in adolescents aged 10-19 years. The remaining $3 million will support the overall best research, irrespective of streams. Up to $1.5M awarded per grant | NHMRC | Closed 3 February 2021, 5pm AEDT | Grant guidelines - Grantconnect |
| 2020 Maternal, First 2000 Days, and Childhood Health Grant Opportunity $12M GrantConnect GO4446 Part of the MRFF Preventive and Public Health Research Initiative | OBJECTIVES To: - foster new discoveries that lead to practice changes in community and clinical settings - increase collaboration across academic disciplines, policy makers and health services to better understand the social, cognitive and emotional aspects of people’s health choices - develop guidance, tools and interventions to support Australians to adopt positive behaviour change and to live active and healthy lives, and - improve health outcomes for Australians living with chronic and complex disease through innovative public health approaches, particularly for Aboriginal and Torres Strait Islander peoples and for disadvantaged regional and rural and culturally and linguistically diverse communities. | NHMRC | Closed 3 February 2021, 5.00pm AEDT | Grant guidelines - GrantConnect |
| 2020 Efficient Use of Existing Medicines Grant Opportunity $7.5M GrantConnect ID GO4450 Part of the MRFF Preventive and Public Health Research Initiative | OBJECTIVE: To support Australian medical research projects that conduct clinical trials to address one of the following topics: - safer and more efficient ways to use high-cost medicines for one or more specific indications without compromising effectiveness. Priority areas include biological agents and other high-cost medicines - other therapeutic indications for existing medicines that are not currently approved by the TGA. Priority areas include off-patent and other low-cost medicines. | NHMRC | Closed 3 February 2021, 5.00pm AEDT | Grant guidelines - GrantConnect |
| 2020 Primary Health Care Research Data Infrastructure Grant Opportunity $10M total Grant size: $1M-$2M GrantConnect GO4428 Part of the MRFF Research Data Infrastructure Initiative | OBJECTIVES: You must also select one or more of the primary health care setting streams that the research project falls under: 1. Residential aged care 2. Urban general practitioner-led practices 3. Rural general practitioner-led practices 4. Aboriginal Community Controlled Health Organisations (ACCHOs) 5. Other settings including, but not limited to, nurses, allied health professionals, midwives, pharmacists, dentists, and Aboriginal health workers | Department of Health via business.gov.au grant portal | Closed 23 February 2021 5.00pm AEDT | www.business.gov.au/mrff-rdi |
| 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity $13M over 2 years (Grants up to $2.5M) GrantConnect GO4453 Part of the MRFF Preventive and Public Health Research Initiative | APPLICANTS: Australian research teams, which must include pharmacy professionals. For joint applications, it is encouraged to have a lead organisation who is the main driver of the project and is eligible to apply. OBJECTIVE: To provide grants of financial assistance to support medical research and medical innovation projects that create or adapt technologies, mechanisms or approaches for improving the quality, safety and effectiveness of medicine use and medicine intervention by pharmacists in primary health and transitions of care. | Department of Health via business.gov.au | Closed 23 February 2021, 5.00pm AEDT | To apply, go to www.business.gov.au/mrff-miu |
| REDI Contestable Program - Round One Managed by MTPConnect | APPLICANT TYPE: Through this program, MTPConnect is calling for partner research, training and industry organisations to deploy an integrated three-pillar plan driving skills and workforce development for the MTP sector nationally. OBJECTIVES: Addressing two of the skills gaps identified in the REDI Skills Gap Analysis Interim Report: 1. Understanding of quality management systems and protocols (linked to advanced manufacturing); and 2. Strategic clinical trial design to meet regulatory requirements and payer needs (linked to commercialisation). | MTPConnect | Closed 15 December 2020, 5pm AEDT | Grant guidelines here. |
| 2021 Frontier Health and Medical Research Initiative $110M - both Stage One and Stage Two are now combined in one application process GrantConnectID GO4359 Announced at the 2020-21 Federal Budget (6 October 2020) | APPLICANT TYPE: research organisations Please note: The 2021 Frontier Health and Medical Research Grant Opportunity now incorporates the entire Frontier process. It now includes both Stage One and Stage Two into a single grant opportunity. OBJECTIVES: - enable researcher collaborations that will explore bold and innovative ideas and/or make discoveries of great potential and global impact, through research relevant to any area of healthcare. - facilitate ground-breaking research with the potential to transform health, across any area of activity within the health system | Department of Health (via the business.gov.au) | Closed Dec 11 2020, 5pm AEDT | Grant guidelines - GrantConnect GO4359 and business.gov.au |
| 2020 Primary Health Care Research Grant Opportunity GrantConnectID GO4236 $4.8M (through to April 2026) Part of the MRFF Primary Health Care Research Initiative | APPLICANT TYPES: Applications must be from NHMRC admininistering institutions. To be competitive for funding, applicants must propose to conduct primary health care research that delivers against the objective. OBJECTIVE: To support primary health care implementation research that builds the evidence base and accelerates development/adoption of best practice clinical care. INTENDED OUTCOME: To improve health outcomes, raise the standard of clinical care and practice, support health system improvement in primary care policy and practice. | NHMRC | Closed 11 November, 2020 5:00pm AEST | Grant guidelines - GrantConnect |
| 2020 Rare Cancers, Rare Diseases and Unmet Need General Grant Opportunity GrantConnectID GO4318 $25M Part of the MRFF Clinical Trial Activity Initiative | APPLICANT TYPES: Applications must be from NHMRC admininistering institutions. OBJECTIVE: To fund clinical trial/s that addresses a gap in current research and/or knowledge in rare cancers, rare diseases and areas of unmet medical need. Applications must address the desired outcomes described in section 1.3 of the grant guidelines. | NHMRC | Closed 11 November, 2020 5:00pm AEST | Grant guidelines - GrantConnect |
| 2020 Medicinal Cannabis Clinical Trials Grant Opportunity GrantConnectID GO4228 $3M over 5 years Part of the MRFF Emerging Priorities and Consumer Driven Research Initiative | APPLICANT TYPES: Applications must be from NHMRC admininistering institutions. OBJECTIVE: To support clinical trials that examine the effects of medicinal cannabis for the management of pain, symptoms and side-effects of cancer and cancer treatment in cancer patients. INTENDED OUTCOMES: To build the evidence base to help medical professionals make informed decisions about the prescription of medicinal cannabis to manage and treat pain, symptoms and side-effects of cancer and cancer treatment. | NHMRC | Closed 11 November, 2020 5:00pm AEST | Grant guidelines - GrantConnect |
| 2020 Mental Health Research Grant Opportunity $24M GrantConnectID GO4285 Part of the MRFF Million Minds Mission | APPLICANT TYPES: Applications must be from NHMRC admininistering institutions. GRANT SIZE: From $8M to $12M It is anticipated two clinical trial networks will be funded - one focussing on children and youth and one on adults. OBJECTIVE: To establish mental health clinical trial networks as part of their research project to ensure effective engagement with clinicians, national collaboration and coordination and rapid implementation into clinical practice. | NHMRC | Closed 11 November, 2020 5:00pm AEST Minimum Data closes 28 October 2020 5:00pm AEST. Questions should be submitted no later than 1:00pm AEST on 4 November 2020 | Grant guidelines - GrantConnect |
| 2020 Brain Cancer Survivorship Grant Opportunity GrantConnect ID GO4046 up to $3M Part of the Australian Brain Cancer Mission | APPLICANT TYPES: A medical research institute, a university, a corporate Commonwealth entity, a corporation (including businesses and not for profits), a state or territory government, a state or territory government entity. Please note that there is a list of ineligible applicants on Grantconnect. OBJECTIVES: - support the development of new approaches and the use of technologies to improve communications between brain cancer survivors, their families, carers and health care professionals; and - understand how information technologies and platforms can be used to support people with brain cancer, their families and carers, and their impact on the physical, psychosocial and economic sequelae of a brain cancer diagnosis. Survivorship research must be focused on children, adolescents and young adults, or adults with malignant brain cancer, their families or carers. | Department of Health (via the business.gov.au portal) | Closes 20 October, 2020 5pm AEST Opened 1 July, 2020 | business.gov.au grants portal. |
| 2020 Rare Cancers Rare Diseases Unmet Need COVID-19 Grant Opportunity $25M GrantConnectID GO4264 Part of the Clinical Trials Activity Initiative Announced 20th August by Minister for Health, Greg Hunt | GRANTS: Funding awarded over 3 years, to commence in early 2021 OBJECTIVE: To fund clinical trials that investigate effective mechanisms for the prevention or treatment of COVID-19 or its symptoms. Applications must propose a clinical trial that addresses a gap in current research and/or knowledge in with a specific focus on COVID-19. Applications must address the desired outcomes described in section 1.3 of the grant guidelines. | NHMRC | Closed 23 September, 2020. | Grant guidelines, application template and assessment details are available on GrantConnect. |
| 2020 COVID-19 Immunological Studies Grant Opportunity Grants up to $1M Total Funding $2M GrantConnect ID: GO4080 Announced by Minister for Health, Greg Hunt, on 2nd June, 2020 | APPLICANT TYPE: Researchers and research teams proposing research that characterises the immune response across COVID-19 patients with asymptomatic, mild, moderate, severe, and critical disease (see grant guidelines for details). OBJECTIVES: The intended outcome of this research is knowledge and evidence that will inform the national health response to COVID-19 and support clinical practice, including: - targeting interventions such as self-isolation - prioritisation of vaccines and / or treatments for high-risk individuals and vulnerable populations. Given the rapidly evolving nature of the COVID-19 pandemic, timely research outcomes relative to the time required to conduct the appropriate research should be proposed. | NHMRC (on behalf of the Department of Health) | Closed 23 July 2020, 5pm AEST | Grant outcomes were announced at the 2020-21 Federal Budget - see Health Budget Stakeholder Pack, p140-145 Grant guidelines available on GrantConnect (GO4080) |
| 2020 COVID-19 Vaccine Candidate Research Grant Opportunity GrantConnect ID: GO4088 Grants up to $3M Total funding available $13.65M 3 rounds available | APPLICANT TYPE: Researchers and research teams. Applicants must also demonstrate access to critical resources necessary to complete the project in the stipulated timeframes. OBJECTIVES: To accelerate the development of promising COVID-19 prophylactic vaccine candidates for which research and development is already underway. Proposals must be focussed on research on a vaccine candidate that has progressed to pre-clinical or clinical investigation with proof-of-concept data. The intended outcome of the research is to support rapid development of a safe and effective COVID-19 prophylactic (disease-preventing) vaccine, which induces active long-term immunity, within the next 12-18 months. | NHMRC (on behalf of the Department of Health) | Round 1 closed 16 July 2020, 5pm AEST - Up to three application rounds over 1 year (2020-21) - Round 2 closes 11 November 2020, 10 March 2021 - A round will comprise two application steps: expression of interest and full applications. | Grant guidelines available on GrantConnect (GO4088) -Applicants and RAOs should also note that the proportion of funds committed after Round 1 may determine whether further Rounds are opened. |
| Coronavirus Research Response - 2020 Rapid Response Digital Health Infrastructure $4M GrantConnect ID GO4051 | OBJECTIVES: The Government is continuing to invest in research to support a national health system response to COVID-19. This grant opportunity will fund high priority digital health infrastructure that has the potential to increase the speed and quality of health system responses during acute crises. Part of the Coronavirus (COVID-19) National Health Plan | Department of Health through business.gov.au grants hub | Closed 14 July, 2020 5pm AEST | Grant guidelines - business.gov.au and GrantConnect |
| Coronavirus Research Response - 2020 Communication Strategies and Approaches During Outbreaks $600K GrantConnect ID GO4050 | OBJECTIVES: The Government is continuing to invest in research to support a national health system response to COVID-19. This grant opportunity will fund research into how diverse communities respond during outbreaks, how they react, access information and interpret it. | Department of Health through business.gov.au grants hub | Closed 14 July, 2020 5pm AEST | Grant guidelines - business.gov.au and GrantConnect |
| Coronavirus Research Response – 2020 COVID-19 Mental Health Research GrantConnect ID: GO4054 $3M Part of the MRFF Million Minds Mission | PROJECT TYPE: Research projects up to $1M each that are expected to deliver results within 12 to 18 months OBJECTIVES: To fund rapid research to improve the national mental health system response to the impacts of the COVID-19 pandemic. These projects will be new research that will help better position our mental health system to be more effective in supporting Australians to manage their mental health and wellbeing, during and following the pandemic. These grants may support work consolidating data systems, and help design and deliver new treatments, services, and policies. The research is expected to also be relevant in future times of hardship, such as natural disasters. | NHMRC (on behalf of the Department of Health) | Closed 13 July, 2020 | Grant Outcomes were announced at the 2020-21 Federal Budget (6 October, 2020) - see the Health Budget Stakeholder Pack, pages 140-145 Grant guidelines - GrantConnect (GO4054) |
| COVID-19 Biomedical Translation Bridge grant Round 3 Rapid COVID-19 Response Funding Opportunity $1m per grant | Funding will support Australian small and medium enterprises, medical research institutes and universities conducting COVID-19 related research projects. Applicants will be required to provide one-to-one matching funding in the form of cash to be eligible. | MTPConnect | CLOSED 01 June 2020 (AEDT) | For Grant Outcomes, see the MTPConnect website - 5 grants were awarded Applications were managed via the MTPConnect website |
| 2020 Targeted Translation Research Accelerator Grant Opportunity GO3744 | APPLICANT TYPE: research organisations OBJECTIVES: The objective of the grant opportunity is to support the development of novel preventive, diagnostic and therapeutic approaches and products for diabetes and cardiovascular disease through a comprehensive package of activities. | Dept of Health (via the business.gov.au portal) | Closed 22 April, 2020 5pm (AEST) | Applications through business.gov.au Grant guidelines - see "Key Documents" |
| MRFF – 2020 Antiviral Development for COVID-19 Grant Opportunity GrantConnectID: GO3825 | APPLICANT TYPE: research organisations OBJECTIVES: grant opportunity must propose research to rapidly identify antiviral candidates targeting SARS-CoV-2 (new and repurposed) and accelerate promising effective treatments that can be made available to treat Australians infected with SARS-CoV-2. | NHMRC | Closed 08 April 2020 Successful grants were announced on 2 June, 2020 by Minister for Health, Greg Hunt. | Applications managed through NHMRC's RGMS Outcomes announced 2 June, 2020 here. |
| MRFF – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity GrantConnectID: GO3817 $5M available. | APPLICANT TYPE: research organisations OBJECTIVES: to use clinical trials to accelerate the implementation of treatments for severe acute respiratory distress in patients infected with COVID 19. To be competitive for funding, applicants must propose a clinical trial that delivers against the above objective. | NHMRC | Closed 06 April, 2020 Successful grants were announced on 2 June, 2020 by Minister for Health, Greg Hunt. | Applications managed through NHMRC's RGMS Outcomes announced 2 June, 2020 here. |
| Research for the novel coronavirus (COVID-19) GrantConnectID: GO3705 $2m available in an open and competitive grant opportunity, part of the EPCDR Initiative. | This Grant Opportunity will complement the world-leading work already undertaken by the Doherty Institute, CSIRO and University of Queensland and their collaboration. | NHMRC | Closed 11 March 2020 | |
| Biomedical Translation Bridge - Round 2 | Up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage | MTPConnect | Closed 06 March 2020 (AEDT) | Round 2 grant outcomes are available on the MTPConnect website - 8 grants were awarded |
| 2020 Traumatic Brain Injury Grant Opportunity GrantConnectID: GO3523 $5M, estimated grant value $1M - $2M Part of the Traumatic Brain Injury Mission | OBJECTIVES: to support clinical research that improves knowledge and its translation into practice in order to enhance personalisation of care after traumatic brain injury. | NHMRC | Closed 04 March 2020 5pm (AEDT) Minimum Data due 26 February 2020, 5pm (AEDT) | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| 2020 Stem Cell Therapies Grant Opportunity GrantConnectID: GO3505 $6M Part of the Stem Cell Therapies Mission | OBJECTIVES: to prime teams working on ‘proof of concept’ stem cell research targeted towards a health care outcome. | NHMRC | Closed 04 March 2020 5pm (AEDT) | Outcomes were announced 22 June, 2020 - see the media release. Managed through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect |
| Rural, Regional and Remote Clinical Trial Enabling Infrastructure Program $100M Part of the MRFF National Critical Infrastructure Initiative | APPLICANT TYPE: Eligible organisations seeking to deliver clinical trial infrastructure projects in rural, regional and remote areas of Australia. PURPOSE OF INITIATIVE: To remove barriers to participating in clinical trials by: - Improving facilities, equipment, services and systems in rural, regional and remote Australia. - Reducing the burden, costs and risks for patients and their families related to clinical trial participation. - Increasing research capacity | Department of Health (via the business.gov.au portal) | Closed 03 March, 2020 5pm (AEDT) | Grant outcomes were announced at the 2020-21 Federal Budget - see Health Budget Stakeholder Pack, p140-145 Grant guidelines now available - see "Key Documents" |
| 2019 Brain Cancer Survivorship Grant Opportunity GrantConnect: GO3557 $5m Part of the Australian Brain Cancer Mission | OBJECTIVES: to support the development of better approaches to address the medical, functional and psychosocial impacts of brain cancer to improve quality of life and the survivorship experience. | Dept of Health (via the business.gov.au portal) | Closed 03 March, 2020 5pm (AEDT) | Outcomes were announced 17 June, 2020 - see the media release Applications through business.gov.au |
| 2019 Applied Artificial Intelligence Research in Health Grant GrantConnect: GO3514 $7.5M Part of the National Critical Research Infrastructure Initiative | OBJECTIVES: - translate or implement innovative AI technologies into health applications that benefit multiple health disciplines/areas - involve consumers in the research journey to ensure the research is applicable to the needs of the Australian community - increase AI workforce capacity and capability, particularly in relation to health, through cross-sector and interdisciplinary collaboration. | Dept of Health (via the business.gov.au portal) | Closed 03 March, 2020 5pm (AEDT) | Grant outcomes announced 29 June, 2020 Grant guidelines - see "Key Documents" |
| Indigenous Health Research - Projects GrantConnectID: GO3394 $13.5M 3 year projects up to $2M each Part of the MRFF $160M 10 year Indigenous Health Research Fund | APPLICANT TYPE: multidisciplinary teams of researchers. Research should be led by Indigenous people and conducted through close engagement with Indigenous communities. PURPOSE OF INITIATIVE: To support practical, innovative health research into the best approaches to prevention, early intervention and treatment in avoidable blindness and deafness, chronic kidney disease and improving adolescent mental health. | NHMRC | Closed 12 February, 2020 5pm (AEDT) | GrantConnect Outcomes from this round were announced 14 June, 2020 |
| 2019 Cardiovascular Health Grant Opportunity GrantConnectID: GO3385 $12M Part of the Cardiovascular Health Mission | OBJECTIVES: - Improving prevention of heart disease and stroke - Improved survival outcomes after an acute heart or stroke event through a focus on treatment - Improving secondary prevention and survivorship after a cardiovascular event | NHMRC | Closed 12 February, 2020 5pm (AEDT) | Applications were managed through NHMRC RGMS. Grant outcomes were announced 5 June, 2020. |
| Global Health Initiative - 2019 Tackling AMR and DR-TB Grant Opportunity GrantConnectID: GO3330 $8M | AIM: to support research that will enhance knowledge and develop tools to combat threats to national health security posed by the regional and global challenges of antimicrobial resistance and drug resistant tuberculosis through international research collaboration | NHMRC | Closed 5 February, 2020 | Grant outcomes were announced 29 June, 2020 Grant guidelines and other essential documents available on GrantConnect |
| 2019 Endometriosis Research Grant Opportunity GrantConnectID: GO3282 $9M over 5 years Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative | APPLICANT TYPE: Australian researchers and research teams PURPOSE OF INITIATIVE: To facilitate innovative, high quality research that will lead to improved diagnosis and treatment of endometriosis including a better understanding of the causes. | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines, assessment scoring matrix and grant proposal template available on GrantConnect. Applications must be from NHMRC Administering Institutions |
| 2019 Ovarian Cancer Research Grant Opportunity GrantConnectID: GO3286 $20M over 4 years Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative | APPLICANT TYPE: Australian researchers and research teams OBJECTIVES OF INITIATIVE: To facilitate innovative, high quality research that will lead to improved diagnosis and treatment of ovarian cancer and lead to a better understanding of the causes. | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines, assessment scoring matrix and grant proposal template available on GrantConnect. Applications must be from NHMRC Administering Institutions |
| 2019 Neurological Disorders Clinical Trial Grant Opportunity GrantConnectID: GO3230 $20M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need (RCRDUM) Initiative | APPLICANT TYPE: Australian research teams proposing one clinical trial PURPOSE OF INITIATIVE: To fund clinical trials that address a gap in current research and/or knowledge in neurological disorders, including (but not limited to) Duchenne Muscular Dystrophy (DMD), spinal cord injuries (SCI) and Autism Spectrum Disorders (ASD). Applications must address the desired outcomes described in section 1.3 of the grant guidelines. | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| 2019 Reproductive Cancers Clinical Trials Grant Opportunity GrantConnectID: GO3227 $15M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need (RCRDUM) Initiative | APPLICANT TYPE: Australian research teams proposing one clinical trial PURPOSE OF INITIATIVE: To fund clinical trials that address a gap in current research and/or knowledge in reproductive cancers including cancers of the cervix, uterus, vulva, fallopian tubes, endometrium or ovaries in women and cancers of the testicles and penis in men (must address the desired outcomes described in section 1.3 of the grant guidelines). | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Guidelines updated 18/11 - grant scope no longer includes prostate cancer research (Guidelines v1.1) Applications must be from NHMRC Administering Institutions |
| 2019 Childhood Brain Cancer Clinical Trial Grant Opportunity GrantConnectID: GO3232 $5M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need (RCRDUM) Initiative | APPLICANT TYPE: Australian research teams proposing one clinical trial PURPOSE OF INITIATIVE: To fund clinical trials that address a gap in current research and/or knowledge in childhood brain cancer (must address the desired outcomes described in section 1.3 of the grant guidelines). | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| 2019 Rare Cancers, Rare Diseases and Unmet Need Clinical Trials Grant Opportunity GrantConnectID: GO3228 $15M funding round as part of the MRFF Rare Cancers Rare Diseases and Unmet Need Initiative | APPLICANT TYPE: Australian research teams proposing one clinical trial PURPOSE OF INITIATIVE: To fund clinical trials that address a gap in current research and/or knowledge in rare cancers, rare diseases and areas of unmet medical need (must address the desired outcomes described in section 1.3 of the grant guidelines). | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| 2019 Suicide Prevention Grant Opportunity GrantConnectID: GO3283 $8M over 4 years Part of the MRFF Million Minds Mission | APPLICANT TYPE: Australian researchers and research teams PURPOSE OF INITIATIVE: The objectives of this grant opportunity are to: • support innovative, high quality, collaborative research that focuses on interventions to prevent suicide • promote effective translation of research into health policy and/or practice • foster and build workforce capacity and workforce capability • leverage collaborations between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare) | NHMRC | Closed 5 February, 2020 | Grant outcomes were announced 25 May, 2020 Applications were through NHMRC's RGMS Grant guidelines are on GrantConnect |
| 2019 Primary Health Care research GrantID: GO3331 $5M as part of the Primary Health Care Research (PHCR) Initiative | OBJECTIVE: The objective of this grant opportunity is to increase Australia’s evidence base in primary health care research for the following priority primary health care research topics: - residential aged care and to older Australians in the community - lessons from comprehensive primary health care service for Indigenous Australians for the broader primary health care system - mental health service provision by general practice - application of precision medicine and genomics in primary health care - rural and regional access to services - workforce issues, including scope of practice - voluntary patient enrolment and blended payments | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| 2019 Targeted Health System and Community Organisation Research Grant Opportunity GrantConnectID: GO3328 $26M funding round as part of the the MRFF Preventive and Public Health Research (PPHR) Initiative | PURPOSE OF INITIATIVE: The five health system research question topics for this grant opportunity are: 1. Cancer treatment population 2. Tools to value health change in paediatric populations 3. Efficient use of high cost pharmaceuticals 4. Digital breast tomosynthesis 5. Circumcision revision | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| 2019 Preventive and Public Health Research Grant Opportunity To support research in: - Maternal health & the first 2000 days - Early childhood - Exercise and nutrition GrantConnectID: GO3326 $11.5M as part of the MRFF Preventive and Public Health Research (PPHR) Initiative | OBJECTIVES: - foster new discoveries that lead to practice changes in community and clinical settings - increase collaboration across academic disciplines, policy makers and health services to better understand the social, cognitive and emotional aspects of people’s health choices - develop guidance, tools and interventions to support Australians to adopt positive behaviour change and to live active and healthy lives, and - improve health outcomes for Australians living with chronic and complex disease through innovative public health approaches, particularly for Aboriginal and Torres Strait Islander peoples and for, disadvantaged regional and rural and culturally and linguistically diverse communities. | NHMRC | Closed 5 February, 2020 | Apply through NHMRC's RGMS Grant guidelines and other essential documents available on GrantConnect Applications must be from NHMRC Administering Institutions |
| Pharmacogenomics to improve mental health treatment outcomes GrantConnectID: GO3329 $7M as part of the Emerging Priorities and Consumer Driven Research (EPCDR) Initiative | OBJECTIVES: - reduce barriers to clinical uptake of pharmacogenomics testing for patients presenting with neuropsychiatric conditions - address gaps in evidence related to the application of pharmacogenomics for neuropsychiatric conditions - encourage research that combines new or existing technologies with large-scale data, machine learning, clinical information, or patient biomarkers to develop new or refine existing tests that facilitate improved personalisation and efficacy of psychotropic medication regimens. | NHMRC | Closed 5 February, 2020 | Grant outcomes were announced 25 May, 2020 Applications were through NHMRC's RGMS Grant guidelines are on GrantConnect |
| 2020 Bushfire Impact Research Grant Opportunity GrantConnectID: GO3529 $5M - Part of the MRFF Emerging Priorities and Consumer Driven Research (EPCDR) Initiative | OBJECTIVES: Rapid response funding for research into the health effects of the bushfires: - Stream 1 - address evidence gaps related to the physiological effects of prolonged exposure to the 2019-20 bushfire events and hazardous bushfire smoke. - Stream 2 - address evidence gaps related to building mental health resilience following the 2019-20 bushfire events and exposure to hazardous bushfire smoke. into mental health effects on people in affected communities. | NHMRC | CLOSED 31 January, 2020 | Grant outcomes have now been published on the MRFF website Applcations were through NHMRC's RGMS and grant guidelines are on GrantConnect |
| Targeted Health System and Community Organisation Research Grant Opportunity - Round 2 GrantConnect ID: GO2361 | APPLICANT TYPE: Australian research teams OBJECTIVES: Health system research topics: 1. Mobile X-ray services - residential aged care facilities 2. Health economics - impacts and costs associated with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) | NHMRC | CLOSED 10 April, 2019 | Apply via NHMRC’s RGMS |
| International Clinical Trial Collaborations Grant Opportunity 2019 Round 1: closed GrantConnect ID: GO1737 $42M over 4 years Up to $4.2M per cycle | APPLICANT TYPE: Australian research teams proposing a single clinical trial OBJECTIVES: • promote Australian involvement in international collaborative investigator-initiated clinical trials research • provide evidence of the effectiveness of novel health treatments, drugs or devices that could then be used in Australia | NHMRC | ICT 2019 Round 1 CLOSED: 10 April, 2019 Continuous applications - 3 peer review cycles per year. | Information on how to apply is available on the NHMRC website. |
| Researcher Exchange and Development within Industry Initiative (REDI) GrantConnect ID: GO2319 $32M over 4 years | APPLICANT TYPE: A service provider who will facilitate connections between industry, universities, registered training organisations and government entities and deliver relevant training programs, industry placements, mentoring and exchange programs for researchers. OBJECTIVES: Strengthening Australia’s success with translation and commercialisation | Dept of Health (via the business.gov.au portal) | CLOSED 9 April, 2019 | Applications were submitted via https://www.business.gov.au/redi |
| Million Minds Mission Grant Opportunity GrantConnect ID: GO2017 $25M over 5 years | APPLICANT TYPE: multidisciplinary teams of researchers OBJECTIVES: To fund research into: • eating disorders • mental health of children and young people • mental health of Aboriginal and Torres Strait Islander peoples. | NHMRC | CLOSED 20 February, 2019 | Applications were submitted via NHMRC’s RGMS |
| Genomics Health Futures Mission - Project Grants Opportunity GrantConnect ID: GO2473 GRANT SIZE: from $100K to $5M over 3 years | APPLICANT TYPE: Australian researchers OBJECTIVES: for innovative and creative genomics research projects on: 1. cancers and diseases with high mortality and low survivability; 2. paediatric acute care genomic research for clinically ill children; 3. ethical, legal and social issues related to genomics in health care | Dept of Health (via the business.gov.au portal) | CLOSED 31 May, 2019 First round - will run over 9 years (2019-20 to 2027-28) | Applications were submitted via business.gov.au/ghfmpg |
| BioMedTech Horizons - Round 2 $1 million of funding over a maximum two-year period | APPLICANT TYPE: for organisations to help progress medical technologies and devices through to Proof of Concept or beyond, the point where they are attractive to secure further venture capital or other funding. OBJECTIVE: to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential. | MTPConnect | ROUND 2 CLOSED 15 July, 2019 | Projects funded in Round 2 are listed on the MTPConnect website here. Expressions of Interest (EOIs) were submitted directly to MTPConnect.Grant guidelines can be found here. |
| International Clinical Trial Collaborations Grant Opportunity 2019 Round 2 GrantConnect ID: GO1737 $42M over 4 years Up to $4.2M per cycle | APPLICANT TYPE: Australian research teams proposing a single clinical trial OBJECTIVES: • promote Australian involvement in international collaborative investigator-initiated clinical trials research • provide evidence of the effectiveness of novel health treatments, drugs or devices that could then be used in Australia | NHMRC | Closed 15 August, 2019 minimum data due 31 July, 2019 Continuous applications - 3 peer review cycles per year. | Information on how to apply is available on the NHMRC website. |
| Biomedical Translation Bridge Program Round 1 | OBJECTIVES: provides up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. | MTPConnect, in partnership with BioCurate (University of Melbourne and Monash University), UniQuest (University of Queensland through its drug discovery initiative QEDDI), the Medical Device Partnering Program (MDPP, led by Flinders University), and the Bridge and BridgeTech programs (Queensland University of Technology) | Closed 16 August, 2019. | Projects funded through Round 1 of the Biomedical Translation Bridge are available on MTPConnect's website here. Expressions of Interest were submitted through MTPConnect's website. |
| Genomics Health Futures Mission Flagships - Pathogen Genomics GrantConnect ID: GO2481 GRANT SIZE: from $1M to $10M over 4 years | APPLICANT TYPE: Australian researchers/research teams OBJECTIVES: large-scale pilot research studies into pathogen genomics late in the research and development pipeline aiming to demonstrate clinical and/or public health utility, cost-effectiveness, and capacity for translation of genomics in the clinic, in recognition that such evidence is critical to the adoption of genomics in mainstream healthcare. | Dept of Health (via the business.gov.au portal) | CLOSED 12 September, 2019 | Grant outcomes were announced at the 2020-21 Federal Budget (6 October, 2020) - see Health Budget Stakeholder Pack, p140-145 See GrantConnect - Sample application forms available 16 July, grant guidelines updated 20 June |
| Accelerated Research - Congenital Heart Disease GrantConnect ID: GO2511 GRANT SIZE: up to $10 million each over 5 years | APPLICANT TYPE: Australian researchers/research teams OBJECTIVES: Ideally projects will align with the National Strategic Action Plan for Childhood Heart Disease, and could target the Research Priorities in the Action Plan in particular: * preventing neurodevelopmental and mental health complications *understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families, or *exploring the role of exercise and increased activity in reducing the impact of CHD. | Dept of Health (via the business.gov.au portal) | CLOSED 12 September, 2019 | Applications were submitted via https://www.business.gov.au/chd |
| Researcher Exchange and Development within Industry Initiative (REDI) GrantConnect ID: GO2827 $8 million in 2019-20 | APPLICANT TYPE: A service provider who will facilitate connections between industry, universities, registered training organisations and government entities and deliver relevant training programs, industry placements, mentoring and exchange programs for researchers. OBJECTIVES: Strengthening Australia’s success with translation and commercialisation | Department of Health (via the business.gov.au portal) | CLOSED 5pm AEST 19 September, 2019 | MTPConnect has been awarded the MRFF funding to run the REDI program - announced 5 February, 2020. For more information on MTPConnect's REDI Program, see their website. See the media release announcing the outcomes here. |
| Medical Research Future Fund - Next Generation Clinical Researchers initiative INVESTIGATOR GRANTS PRIORITY ROUND GrantConnect ID: GO3039 Funding will be available to support applications commencing in both 2020 and 2021. | APPLICANT TYPE: Restricted to researchers applying at Emerging Leadership Level 1 and 2 (EL1 and EL2) Investigator Grants (see grant guidelines) | NHMRC via NHMRC’s Investigator Grants 2020 scheme | Closed 27 November, 2019 | Outcomes for this grant round were announced 21 May, 2020 and are available here. |
| International Clinical Trial Collaborations Grant Opportunity 2019 Round 3 GrantConnect ID: GO1737 $42M over 4 years Up to $4.2M per cycle | APPLICANT TYPE: Australian research teams proposing a single clinical trial OBJECTIVES: • promote Australian involvement in international collaborative investigator-initiated clinical trials research • provide evidence of the effectiveness of novel health treatments, drugs or devices that could then be used in Australia | NHMRC | Closed 5pm AEDT 4 December, 2019 minimum data due 20 November, 2019 Continuous applications - 3 peer review cycles per year. | Information on how to apply is available on the NHMRC website. |
| BioMedTech Horizons Round 3 $1 million of funding over a maximum two-year period | APPLICANT TYPE: for organisations to help progress medical technologies and devices through to Proof of Concept or beyond, the point where they are attractive to secure further venture capital or other funding. OBJECTIVE: to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential. | MTPConnect | Round 3 closed 16 December, 2019 5pm AEDT | Applicants applied here Grant guidelines available here For more information, see MTPConnect. |
